2014 Q4 Form 10-Q Financial Statement

#000107997314000566 Filed on November 10, 2014

View on sec.gov

Income Statement

Concept 2014 Q4 2014 Q3 2013 Q3
Revenue $79.00K $36.00K $56.00K
YoY Change -35.71% 833.33%
Cost Of Revenue $30.00K $12.39K $21.23K
YoY Change -41.63%
Gross Profit $51.00K $24.00K $35.00K
YoY Change -31.43% 483.33%
Gross Profit Margin 64.56% 66.67% 62.5%
Selling, General & Admin $1.520M $1.473M $1.323M
YoY Change 7.8% 11.36% -1.74%
% of Gross Profit 2980.39% 6138.75% 3779.93%
Research & Development $900.0K $1.119M $1.806M
YoY Change -45.45% -38.04% 69.46%
% of Gross Profit 1764.71% 4663.81% 5161.07%
Depreciation & Amortization $70.00K $47.00K $150.0K
YoY Change -12.5% -68.67% 64.84%
% of Gross Profit 137.25% 195.83% 428.57%
Operating Expenses $2.390M $2.593M $3.129M
YoY Change -21.64% -17.15% 29.72%
Operating Profit -$2.339M -$2.545M -$3.073M
YoY Change -23.31% -17.19% 27.95%
Interest Expense -$20.00K $27.19K $31.90K
YoY Change -80.0% -14.76%
% of Operating Profit
Other Income/Expense, Net $0.00 $11.16K $713.00
YoY Change -100.0% 1464.52% -101.22%
Pretax Income -$2.370M -$2.530M -$3.070M
YoY Change -24.28% -17.59% 24.8%
Income Tax
% Of Pretax Income
Net Earnings -$2.370M -$2.533M -$3.072M
YoY Change -24.28% -17.55% 24.88%
Net Earnings / Revenue -3000.0% -7036.11% -5485.71%
Basic Earnings Per Share
Diluted Earnings Per Share -$610.8K -$653.7K -$1.146M
COMMON SHARES
Basic Shares Outstanding 30.99M shares 30.99M shares 21.45M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q4 2014 Q3 2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $24.50M $26.70M $17.30M
YoY Change 71.33% 54.34% 69.61%
Cash & Equivalents $3.540M $4.371M $4.355M
Short-Term Investments $21.00M $22.30M $12.90M
Other Short-Term Assets $400.0K $500.0K $500.0K
YoY Change -20.0% 0.0% 0.0%
Inventory
Prepaid Expenses
Receivables $17.00K $12.00K $56.07K
Other Receivables $0.00
Total Short-Term Assets $24.90M $27.25M $17.85M
YoY Change 68.66% 52.7% 66.88%
LONG-TERM ASSETS
Property, Plant & Equipment $2.104M $2.132M $2.319M
YoY Change -7.19% -8.08% -9.42%
Goodwill $387.2K $387.2K $387.2K
YoY Change 0.0% 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.724M $1.667M $1.616M
YoY Change 6.95% 3.18% 2.97%
Total Long-Term Assets $3.828M $3.799M $3.935M
YoY Change -1.32% -3.45% -4.71%
TOTAL ASSETS
Total Short-Term Assets $24.90M $27.25M $17.85M
Total Long-Term Assets $3.828M $3.799M $3.935M
Total Assets $28.72M $31.05M $21.78M
YoY Change 54.1% 42.55% 46.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $437.5K $521.4K $870.4K
YoY Change -43.94% -40.09% 35.56%
Accrued Expenses $325.4K $463.4K $972.2K
YoY Change -64.15% -52.34% 47.56%
Deferred Revenue
YoY Change
Short-Term Debt $160.4K $0.00 $0.00
YoY Change -7.54%
Long-Term Debt Due $300.0K $400.0K $400.0K
YoY Change 0.0% 0.0% -84.62%
Total Short-Term Liabilities $1.782M $1.788M $2.401M
YoY Change -20.77% -25.51% -44.14%
LONG-TERM LIABILITIES
Long-Term Debt $2.000M $2.000M $2.200M
YoY Change -9.09% -9.09% 175.0%
Other Long-Term Liabilities $1.300M $1.300M $1.300M
YoY Change 0.0% 0.0% 30.0%
Total Long-Term Liabilities $3.300M $3.300M $3.500M
YoY Change -5.71% -5.71% 94.44%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.782M $1.788M $2.401M
Total Long-Term Liabilities $3.300M $3.300M $3.500M
Total Liabilities $5.039M $5.108M $5.913M
YoY Change -11.45% -13.62% -2.45%
SHAREHOLDERS EQUITY
Retained Earnings -$96.82M -$94.45M -$83.25M
YoY Change 12.09% 13.46% 16.06%
Common Stock $99.12M
YoY Change 23.15%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $23.69M $25.94M $15.87M
YoY Change
Total Liabilities & Shareholders Equity $28.72M $31.05M $21.78M
YoY Change 54.1% 42.55% 46.94%

Cashflow Statement

Concept 2014 Q4 2014 Q3 2013 Q3
OPERATING ACTIVITIES
Net Income -$2.370M -$2.533M -$3.072M
YoY Change -24.28% -17.55% 24.88%
Depreciation, Depletion And Amortization $70.00K $47.00K $150.0K
YoY Change -12.5% -68.67% 64.84%
Cash From Operating Activities -$1.950M -$2.290M -$2.570M
YoY Change -30.36% -10.89% 375.93%
INVESTING ACTIVITIES
Capital Expenditures -$100.0K -$20.00K -$30.00K
YoY Change 100.0% -33.33% -40.0%
Acquisitions
YoY Change
Other Investing Activities $1.350M $3.040M -$2.680M
YoY Change -68.53% -213.43% 1388.89%
Cash From Investing Activities $1.250M $3.010M -$2.700M
YoY Change -70.52% -211.48% 1073.91%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -140.0K -100.0K -100.0K
YoY Change 0.0% 0.0% -71.43%
NET CHANGE
Cash From Operating Activities -1.950M -2.290M -2.570M
Cash From Investing Activities 1.250M 3.010M -2.700M
Cash From Financing Activities -140.0K -100.0K -100.0K
Net Change In Cash -840.0K 620.0K -5.370M
YoY Change -164.62% -111.55% 379.46%
FREE CASH FLOW
Cash From Operating Activities -$1.950M -$2.290M -$2.570M
Capital Expenditures -$100.0K -$20.00K -$30.00K
Free Cash Flow -$1.850M -$2.270M -$2.540M
YoY Change -32.73% -10.63% 418.37%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
222048 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
251900 USD
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
2951 USD
us-gaap Recognition Of Deferred Revenue
RecognitionOfDeferredRevenue
71524 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
34000 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
34000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
USD
us-gaap Net Income Loss
NetIncomeLoss
-8072549 USD
us-gaap Net Income Loss
NetIncomeLoss
-9018878 USD
us-gaap Interest Paid
InterestPaid
79879 USD
us-gaap Interest Paid
InterestPaid
110519 USD
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
56068 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1287437 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-6622634 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5658683 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10977974 USD
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4371246 USD
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4355340 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
345657 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
789058 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
20122652 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
12969587 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
19776995 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
12180529 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
14512 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
24241 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
127346 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
79055 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-13809603 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-11872959 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-7254829 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-6930204 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
32486785 USD
CY2014Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
214074 USD
CY2013Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
332250 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
425 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
1293 USD
CY2014Q3 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
213988 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
17759448 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
18785040 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
5989785 USD
us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
150830 USD
us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-409335 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-444367 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
330190 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
68585 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
317485 USD
us-gaap Recognition Of Deferred Revenue
RecognitionOfDeferredRevenue
61612 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4730 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-236999 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-229135 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-259067 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
256431 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
943486 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1227597 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5843000 shares
CY2014Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
12000 USD
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
85000 USD
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
85000 USD
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
85000 USD
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
85000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
57000 USD
CY2014Q3 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
USD
CY2014Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
484447 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
422261 USD
CY2014Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1279957 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1214797 USD
CY2014Q3 us-gaap Goodwill
Goodwill
387239 USD
CY2013Q4 us-gaap Goodwill
Goodwill
387239 USD
CY2014Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5321000 shares
CY2014Q3 appy Percentage Of Investment Portfolio Cash And Cash Equivalent
PercentageOfInvestmentPortfolioCashAndCashEquivalent
0.12 pure
us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
22000 USD
us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
13000 USD
CY2013Q3 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 USD
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
85000 USD
CY2013Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
10124 USD
CY2014Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1667196 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1612160 USD
CY2014Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
21000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
19000 USD
CY2013Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
62000 USD
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1580000 USD
us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
1161570 shares
CY2014Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.36
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
82000 USD
CY2013Q3 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
332150 USD
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
943061 USD
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
1226304 USD
CY2014Q3 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
86 USD
CY2013Q3 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
100 USD
us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
4025000 shares
CY2014Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
0.35 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
1912205 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
3673126 shares
CY2014Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5375414 USD
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5497099 USD
CY2014Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3243658 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3230117 USD
CY2014Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2131756 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2266982 USD
CY2014Q3 us-gaap Depreciation
Depreciation
47000 USD
us-gaap Depreciation
Depreciation
59000 USD
CY2013Q3 us-gaap Depreciation
Depreciation
150000 USD
us-gaap Depreciation
Depreciation
190000 USD
CY2014Q3 us-gaap Assets
Assets
31050944 USD
CY2013Q4 us-gaap Assets
Assets
18639869 USD
CY2014Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
521447 USD
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
780514 USD
CY2014Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
299752 USD
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
148922 USD
CY2014Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
463365 USD
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
907732 USD
CY2014Q3 us-gaap Notes Payable Current
NotesPayableCurrent
407219 USD
CY2013Q4 us-gaap Notes Payable Current
NotesPayableCurrent
319771 USD
CY2014Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
96698 USD
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
92084 USD
CY2014Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1788481 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2249023 USD
CY2014Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
2036189 USD
CY2013Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
2150608 USD
CY2014Q3 us-gaap Short Term Investments
ShortTermInvestments
22344393 USD
CY2013Q4 us-gaap Short Term Investments
ShortTermInvestments
8642648 USD
CY2014Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
536353 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
459396 USD
CY2014Q3 us-gaap Assets Current
AssetsCurrent
27251992 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
14760727 USD
CY2014Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1282888 USD
CY2013Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1290441 USD
CY2014Q3 us-gaap Liabilities
Liabilities
5107558 USD
CY2013Q4 us-gaap Liabilities
Liabilities
5690072 USD
CY2013Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2014Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30990029 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21454380 shares
CY2014Q3 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
120397723 USD
CY2013Q4 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
99331585 USD
CY2014Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-94454337 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-86381788 USD
CY2014Q3 us-gaap Stockholders Equity
StockholdersEquity
25943386 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
12949797 USD
CY2014Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
31050944 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18639869 USD
CY2014Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
30990029 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21454380 shares
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2014Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2013Q3 us-gaap Recognition Of Deferred Revenue
RecognitionOfDeferredRevenue
21708 USD
CY2014Q3 us-gaap Other Commitment Due In Next Twelve Months
OtherCommitmentDueInNextTwelveMonths
20000 USD
CY2014Q3 appy License Agreement Maximum Milestone Payments
LicenseAgreementMaximumMilestonePayments
1100000 USD
CY2014Q3 appy Additional Milestone Maximum Payments
AdditionalMilestoneMaximumPayments
2000000 USD
CY2014Q3 us-gaap Recognition Of Deferred Revenue
RecognitionOfDeferredRevenue
24175 USD
CY2014Q3 appy License And Milestone Payments Revenue
LicenseAndMilestonePaymentsRevenue
1920000 USD
CY2014Q3 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
363700 USD
CY2014Q3 appy Deferred Revenue Gross
DeferredRevenueGross
1556300 USD
CY2014Q3 appy Deferred Revenue Accumulated Recognition
DeferredRevenueAccumulatedRecognition
176714 USD
CY2014Q3 us-gaap Deferred Revenue
DeferredRevenue
1379586 USD
CY2014Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
1543000 USD
CY2014Q2 appy Placement Fee Percentage
PlacementFeePercentage
0.065 pure
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
39079 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
14000 USD
CY2013Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
11500000 shares
CY2013Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
1.25
CY2013Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
14400000 USD
CY2013Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
1405000 USD
CY2014Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0 USD
CY2014Q3 us-gaap Investments And Cash
InvestmentsAndCash
26716000 USD
CY2014Q3 appy Working Capital
WorkingCapital
25464000 USD
CY2013Q2 appy Placement Fee Percentage
PlacementFeePercentage
0.07 pure
CY2013Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
0.35 shares
CY2013Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
4025000 shares
CY2013Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.36
CY2013Q2 appy Underwriter Addtional Shares Percentage
UnderwriterAddtionalSharesPercentage
0.15 pure
CY2014Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
8335000 shares
CY2014Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
2.40
CY2014Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
20000000 USD
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3072803 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-8048972 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-9027679 USD
CY2014Q3 us-gaap Interest Expense
InterestExpense
27188 USD
CY2013Q3 us-gaap Interest Expense
InterestExpense
31897 USD
us-gaap Interest Expense
InterestExpense
89746 USD
us-gaap Interest Expense
InterestExpense
106703 USD
CY2014Q3 us-gaap Investment Income Net
InvestmentIncomeNet
4343 USD
CY2013Q3 us-gaap Investment Income Net
InvestmentIncomeNet
7138 USD
us-gaap Investment Income Net
InvestmentIncomeNet
32169 USD
us-gaap Investment Income Net
InvestmentIncomeNet
39379 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
76125 USD
CY2014Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
11155 USD
CY2013Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
713 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-23577 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8801 USD
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-2533381 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-3072090 USD
CY2014Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
CY2013Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.14
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.29
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.58
CY2014Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
30990029 shares
CY2013Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
21454380 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
27838257 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
15430570 shares
CY2014Q3 us-gaap Secured Debt
SecuredDebt
2187801 USD
CY2013Q4 us-gaap Secured Debt
SecuredDebt
2296919 USD
CY2013Q4 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
173460 USD
CY2014Q3 us-gaap Notes Payable
NotesPayable
2443408 USD
CY2013Q4 us-gaap Notes Payable
NotesPayable
2470379 USD
CY2014Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
132000 USD
CY2014Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
313000 USD
CY2014Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
159000 USD
CY2014Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
166000 USD
CY2014Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
1268000 USD
CY2014Q3 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
405000 USD
us-gaap Gross Profit
GrossProfit
43726 USD
CY2014Q3 us-gaap Licenses Revenue
LicensesRevenue
24175 USD
CY2013Q3 us-gaap Licenses Revenue
LicensesRevenue
21708 USD
us-gaap Licenses Revenue
LicensesRevenue
71524 USD
CY2014Q3 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
255607 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
56068 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
21230 USD
us-gaap Gross Profit
GrossProfit
34838 USD
CY2014Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
34000 USD
CY2013Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
25472 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
34000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
88024 USD
CY2014Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
36296 USD
CY2014Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
12391 USD
CY2014Q3 us-gaap Gross Profit
GrossProfit
23905 USD
CY2013Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
56068 USD
CY2013Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
21230 USD
CY2013Q3 us-gaap Gross Profit
GrossProfit
34838 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
44298 USD
us-gaap Licenses Revenue
LicensesRevenue
61612 USD
CY2014Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1473301 USD
CY2013Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1322976 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5042462 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4105261 USD
CY2014Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1119315 USD
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1806373 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3121760 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5018868 USD
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
2592616 USD
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
3129349 USD
us-gaap Operating Expenses
OperatingExpenses
8164222 USD
us-gaap Operating Expenses
OperatingExpenses
9124129 USD
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2544536 USD
dei Entity Registrant Name
EntityRegistrantName
Venaxis, Inc.
dei Entity Central Index Key
EntityCentralIndexKey
0001167419
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2014-09-30
dei Amendment Flag
AmendmentFlag
false
CY2014Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
30990029 shares
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3

Files In Submission

Name View Source Status
0001079973-14-000566-index-headers.html Edgar Link pending
0001079973-14-000566-index.html Edgar Link pending
0001079973-14-000566.txt Edgar Link pending
0001079973-14-000566-xbrl.zip Edgar Link pending
appy-20140930.xml Edgar Link completed
appy-20140930.xsd Edgar Link pending
appy-20140930_cal.xml Edgar Link unprocessable
appy-20140930_def.xml Edgar Link unprocessable
appy-20140930_lab.xml Edgar Link unprocessable
appy-20140930_pre.xml Edgar Link unprocessable
appy_10q-093014.htm Edgar Link pending
ex31x1.htm Edgar Link pending
ex31x2.htm Edgar Link pending
ex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending